Relaunched doctor reward scheme is missed opportunity for fairer reform
Professor Mark Exworthy and colleagues claim that the new National Clinical Impact Awards (NCIAs) are insensitive to the needs of the wider NHS workforce.
Professor Mark Exworthy and colleagues claim that the new National Clinical Impact Awards (NCIAs) are insensitive to the needs of the wider NHS workforce.
The new national scheme for rewarding clinical excellence in the NHS is a missed opportunity to design a fairer system and one that recognises the collective effort of teams over individuals, according to a new paper.
Writing in the Journal of the Royal Society of Medicine, Professor Mark Exworthy and colleagues say that the new National Clinical Impact Awards (NCIAs) (formerly the Clinical Excellence Awards (CEAs)), which are awarded to individual doctors, are insensitive to the needs of the wider NHS workforce. Now more than ever, healthcare and innovation in the NHS is reliant on teamwork, and this should have been reflected in the design of the new scheme, they argue.
Launched in January 2022, the NCIAs introduced several changes to try to broaden access, make it simpler, fairer and more inclusive, and reward a broader spectrum of work and behaviours.
Predecessors to the current scheme were widely criticised for, among other things, inequalities among race, gender and between specialties, with female and ethnic minority applicants underrepresented at all award levels. The Department for Health and Social Care’s 2020 Mend the Gap report, for example, found that the CEAs contributed toward the broader 20% gender pay gap in medicine.
These concerns are likely to persist, say the researchers, from a range of institutions across England. While welcoming changes such as increasing the number of awards, providing ‘improved guidance materials, alongside a communications strategy to raise greater awareness of the scheme’ and improved reporting of data, they are sceptical that they represent firm commitments or goals to address longstanding gender and ethnic disparities. They also remain unconvinced that this scheme will have an impact on patient care, or that these changes provide an objective measure of impact applicable across the diversity of medical specialties and outputs.
They call for more research into the effectiveness of such schemes and say there is currently little evidence to support their ongoing use and effectiveness. They conclude that the NCIA reforms seem tokenistic and represent a missed opportunity to abolish this scheme and usher in a fairer pay scheme for all.
Essex R, Rao M, Mir F, Surash S, Exworthy M. (2022) The National Clinical Impact Awards: cosmetic change or fundamental reform? Journal of the Royal Society of Medicine.. doi:10.1177/01410768221108499
The narrow focus of this investigation still overlooks the most critical elements of these awards, namely whether they improve the delivery of care.